Nitric oxide donor-induced persistent inhibition of cell adhesion protein expression and NFκB activation in endothelial cells

Nitric Oxide - Biology and Chemistry

Volumn 15, Issue 2, 2006, Pages 103-113

  Waldow, Thomas ^a   Witt, Wolfgang ^a   Weber, Elvis ^a   Matschke, Klaus ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Cell adhesion molecule; Cytokine; I B ; IKK ; Nitric oxide

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; 8 BROMO CYCLIC GMP; BIOTIN; CELL ADHESION MOLECULE; CYCLIC GMP; CYSTEINE; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GUANYLATE CYCLASE INHIBITOR; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE DONOR; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INCUBATION TIME; ISCHEMIA; NITROSATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REPERFUSION INJURY;

CELL ADHESION MOLECULES; CELLS, CULTURED; CYCLIC GMP; CYSTEINE; ENDOTHELIAL CELLS; GUANYLATE CYCLASE; HUMANS; I-KAPPA B KINASE; I-KAPPA B PROTEINS; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; NF-KAPPA B; NITRIC OXIDE DONORS; OXADIAZOLES; QUINOXALINES; S-NITROSO-N-ACETYLPENICILLAMINE; THIONUCLEOTIDES; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

BACTERIA (MICROORGANISMS);

EID: 33746806279     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2005.12.005     Document Type: Article

References (56)

1. Pasupathy S., and Homer-Vanniasinkam S. Ischaemic preconditioning protects against ischemia/reperfusion injury: emerging concepts. Eur. J. Vasc. Endovasc. Surg. 29 (2005) 106-115
2. Küntschler M.V., Kastell T., Altmann J., Menke H., Gebhard M.M., and Germann G. Acute remote ischemic preconditioning II: the role of nitric oxide. Microsurgery 22 (2002) 227-231
3. Nakano A., Liu G.S., Heusch G., Downey J.M., and Cohen M.V. Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning. J. Mol. Cell. Cardiol. 32 (2000) 1159-1167
4. Hill M., Takano H., Tang X., Kodani E., Shirk G., and Bolli R. Nitroglycerin induces late preconditioning against myocardial infarction in conscious rabbits despite development of nitrate tolerance. Circulation 104 (2002) 694-699
5. ATP-dependent mechanism. Am. J. Physiol. Heart Circ. Physiol. 287 (2004) H712-H718
6. Fujino S., Nagahiro I., Triantafillou A.N., Boasquevisque C.H.R., Yano M., Cooper J.D., and Patterson G.A. Inhaled nitric oxide at the time of harvest improves early lung allograft function. Ann. Thorac. Surg. 63 (1997) 1383-1390
7. Guery B., Neviere R., Viget N., Foucher C., Fialdes P., Wattel F., and Beaucaire G. Inhaled NO preadministration modulates local and remote ischemia-reperfusion organ injury in a rat model. J. Appl. Physiol. 87 (1999) 47-53
8. Schütte H., Witzenrath M., Mayer K., Rosseau S., Seeger W., and Grimminger F. Short-term "preconditioning" with inhaled nitric oxide protects rabbit lungs against ischemia-reperfusion injury. Transplantation 72 (2001) 1363-1370
9. Jheon S., Lee Y.M., Sung S.W., Choh J.H., Kwon K.Y., Keum D.Y., and Park C.K. Pulmonary preservation effect of nitroglycerine in isolated rat lung reperfusion model. Transplant. Proc. 36 (2004) 1933-1935
10. Waldow T., Alexiou K., Witt W., Wagner F.M., Kappert U., Knaut M., and Matschke K. Protection of lung tissue against ischemia/reperfusion injury by preconditioning with inhaled nitric oxide in an in situ pig model of normothermic pulmonary ischemia. Nitric Oxide 10 (2004) 198-205
11. Waldow T., Alexiou K., Witt W., Wagner F.M., Gulielmos V., Matschke K., and Knaut K. Attenuation of reperfusion-induced systemic inflammation by preconditioning with nitric oxide in an in situ porcine model of normothermic lung ischemia. Chest 125 (2004) 2253-2259
12. Hotter G., Closa D., Prados M., Fernández-Cruz L., Prats N., Gelpí E., and Roselló-Catafau J. Intestinal preconditioning is mediated by a transient increase in nitric oxide. Biochem. Biophys. Res. Commun. 222 (1996) 27-32
13. Rakhit R.D., Edwards R.J., Mockridge J.W., Baydoun A.R., Wyatt A.W., Mann G.E., and Marber M.S. Nitric oxide-induced cardioprotection in cultured rat ventricular myocytes. Am. J. Physiol. Heart Circ. Physiol. 278 (2000) H1211-H1218
14. Mehta J.L., Chen H.J., and Li D.Y. Protection of myocytes from hypoxia-reoxygenation injury by nitric oxide is mediated by modulation of transforming growth factor-β. Circulation 105 (2002) 2206-2211
15. ATP channels, and ERK. Am. J. Physiol. Heart Circ. Physiol. 286 (2004) H1433-H1440
16. Takano H., Tang X., Qiu Y., Guo Y., French B.A., and Bolli R. Nitric oxide donors induce late preconditioning against myocardial stunning and infarction in conscious rabbits via an antioxidant-sensitive mechanism. Circ. Res. 83 (1998) 73-84
17. Alencar J.L., Lobysheva I., Geffard M., Sarr M., Schott C., Schini-Kerth V.B., Nepveu F., Stoclet J.-C., and Muller B. Role of S-nitrosation of cysteine residues in long-lasting inhibitory effect of nitric oxide on arterial tone. Mol. Pharmacol. 63 (2003) 1148-1158
18. Alencar J.L., Lobysheva I., Chalupsky K., Geffard M., Nepveu F., Stoclet J.-C., and Muller B. S-Nitrosating nitric oxide donors induce long-lasting inhibition of contraction in isolated arteries. J. Pharmacol. Exp. Ther. 307 (2003) 152-159
19. Rodriguez J., Maloney R.E., Rassaf T., Bryan N.S., and Feelisch M. Chemical nature of nitric oxide storage forms in rat vascular tissue. Proc. Natl. Acad. Sci. USA 100 (2003) 336-341
20. Bryan N.S., Rassaf T., Maloney R.E., Rodriguez C.M., Saijo F., Rodriguez J.R., and Feelisch M. Cellular targets and mechanisms of nitros(yl)ation: an insight into their nature and kinetics in vivo. Proc. Natl. Acad. Sci. USA 101 (2004) 4308-4313
21. Janero D.R., Bryan N.S., Saijo F., Dhawan V., Schwalb D.J., Warren M.C., and Feelish M. Differential nitros(yl)ation of blood and tissue constituents during glyceryl trinitrate biotransformation in vivo. Proc. Natl. Acad. Sci. USA 101 (2004) 16958-16963
22. Hess D.T., Matsomoto A., Kim S., Marshall H.E., and Stamler J.S. Protein S-nitrosylation: purview and parameters. Nat. Rev. Mol. Cell Biol. 6 (2005) 150-166
23. Stamler J.S., Lamas S., and Fang F.C. Nitrosylation: the prototypic redox-based signaling mechanism. Cell 106 (2001) 675-683
24. Maejima Y., Adachi S., Morikawa K., Ito H., and Isobe M. Nitric oxide inhibits myocardial apoptosis by preventing caspase-3 activity via S-nitrosylation. J. Mol. Cell. Cardiol. 38 (2005) 163-174
25. Wagner J.G., and Roth R.A. Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature. Pharmacol. Rev. 52 (2000) 349-374
26. de Perrot M., Liu M., Waddell T.K., and Keshavjee S. Ischemia-reperfusion-induced lung injury. Am. J. Respir. Crit. Care Med. 167 (2003) 490-511
27. De Caterina R., Libby P., Peng H.-B., Thannickal V.J., Rajavashisth T.B., Gimbrone Jr. M.A., Shin W.S., and Liao J.K. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules. J. Clin. Invest. 96 (1995) 60-68
28. Khan B.V., Harrison D.G., Olbrych M.T., Alexander R.W., and Medford R.M. Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc. Natl. Acad. Sci. USA 93 (1996) 9114-9119
29. Kupatt C., Weber C., Wolf D.A., Becker B.F., Smith T.W., and Kelly R.A. Nitric oxide attenuates reoxygenation-induced ICAM-1 expression in coronary microvascular endothelium: role of NFκB. J. Mol. Cell. Cardiol. 29 (1997) 2599-2609
30. Spiecker M., Darius H., Kaboth K., Hübner F., and Liao J.K. Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants. J. Leukoc. Biol. 63 (1998) 732-739
31. Karin M., and Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18 (2000) 621-663
32. Reynaert N.L., Ckless K., Korn S.H., Vos N., Guala A.S., Wouters E.F.M., van der Vliet A., and Janssen-Heininger Y.M.W. Nitric oxide represses inhibitory κB kinase through S-nitrosylation. Proc. Natl. Acad. Sci. USA 101 (2004) 8945-8950
33. Mallis R.J., and Thomas J.A. Effect of S-nitrosothiols on cellular glutathione and reactive protein sulfhydryls. Arch. Biochem. Biophys. 383 (2000) 60-69
34. Nemoto T., Shimma N., Horie S., Saito T., Okuma Y., Nomura Y., and Murayama T. Involvement of the system L amino acid transporter on uptake of S-nitroso-l-cysteine, an endogenous S-nitrosothiol, in PC12 cells. Eur. J. Pharmacol. 458 (2003) 17-24
35. Jaffrey S.R., Erdjument-Bromage H., Ferris C.D., Tempst P., and Snyder S.H. Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat. Cell Biol. 3 (2001) 193-197
36. Chang K., Lee S.-J., Cheong I., Billar T.R., Chung H.-T., Han J.-A., Kwon Y.-G., Ha K.-S., and Kim Y.-M. Nitric oxide suppresses inducible nitric oxide synthase expression by inhibited post-translational modification of IκB. Exp. Mol. Med. 36 (2004) 311-324
37. Wong D., Prameya R., Dorovini-Zis K., and Vincent S.R. Nitric oxide regulates interactions of PMN with human brain microvessel endothelial cells. Biochem. Biophys. Res. Commun. 323 (2004) 142-148
38. Minami T., and Aird W.C. Thrombin stimulation of the vascular cell adhesion molecule-1 promoter in endothelial cells is mediated by tandem nuclear factor-κB and GATA motifs. J. Biol. Chem. 276 (2001) 47632-47641
39. Chen X.L., Varner S.E., Rao A.S., Grey J.Y., Thomas S., Cook C.K., Wasserman M.A., Medford R.M., Jaiswal A.K., and Kunsch C. Laminar flow induction of antioxidant response element-mediated genes in endothelial cells. A novel anti-inflammatory mechanism. J. Biol. Chem. 278 (2003) 703-711
40. Pierce J.W., Schoenleber R., Jesmok G., Best J., Moore S.A., Collins T., and Gerritsen M.E. Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J. Biol. Chem. 272 (1997) 21096-21103
41. Peng H.-B., Libby P., and Liao J.K. Induction and stabilization of IκBα by nitric oxide mediates inhibition of NF-κB. J. Biol. Chem. 270 (1995) 14214-14219
42. Katsuyama K., Shichiri M., Marumo F., and Hirata Y. NO inhibits cytokine-induced iNOS expression and NF-κB activation by interfering with phosphorylation and degradation of IκB-α. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 1796-1802
43. Waldow T., Alexiou K., Witt W., Albrecht S., Wagner F., Knaut M., and Matschke K. Protection against acute porcine lung ischemia/reperfusion injury by systemic preconditioning via hind limb ischemia. Transplant. Int. 18 (2005) 198-205
44. Ignarro L.J., Napoli C., and Loscalzo J. Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide. An overview. Circ. Res. 90 (2002) 21-28
45. Zhang Y., and Hogg N. S-Nitrosothiols: cellular formation and transport. Free Radic. Biol. Med. 38 (2005) 831-838
46. Braam B., de Roos R., Dijk A., Boer P., Post J.A., Kemmeren P.P.C.W., Holstege F.C.P., Bluysen H.A.R., and Koomans H.A. Nitric oxide donor induces temporal and dose-dependent reduction of gene expression in human endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 287 (2004) H1977-H1986
47. Beg A.A., Finco T.S., Nantermet P.V., and Baldwin A.S. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBα: a mechanism for NF-κB activation. Mol. Cell. Biol. 13 (1993) 3301-3310
48. Hoffmann A., Levchenko A., Scott M.L., and Baltimore D. The IκB-NF-κB signalling module: temporal control and selective gene activation. Science 298 (2002) 1241-1245
49. Nelson D.E., Ihekwaba A.E.C., Elliott M., Johnson J.R., Gibney C.A., Foreman B.E., Nelson G., See V., Horton C.A., Spiller D.G., Edwards S.W., McDowell H.P., Unitt J.F., Sullivan E., Grimley R., Benson N., Broomhead D., Kell D.B., and White M.R.H. Oscillations in NF-κB signalling control the dynamics of gene expression. Science 306 (2004) 704-708
50. Chen L.-F., and Greene W.C. Shaping the nuclear action of NF-κB. Nat. Rev. Mol. Cell Biol. 5 (2004) 392-401
51. Matthews J.R., Botting C.H., Panico M., Morris H.R., and Hay R.T. Inhibition of NF-κB DNA binding by nitric oxide. Nucleic Acids Res. 24 (1996) 2236-2242
52. Imbert V., Rupec R.A., Livolsi A., Pahl H.L., Traenckner E.B., Mueller-Dieckmann C., Farahifar D., Rossi B., Auberger P., Baeuerle P.A., and Peyron J.-F. Tyrosine phosphorylation of IκB-α activates NF-κB without proteolytic degradation of IκB-α. Cell 86 (1996) 787-798
53. Singh S., Darnay B.G., and Aggarwal B.B. Site-specific tyrosine phosphorylation of IκBα negatively regulates its inducible phosphorylation and degradation. J. Biol. Chem. 271 (1996) 31049-31054
54. Johnson D.R., Douglas I., Jahnke A., Ghosh S., and Pober J.S. A sustained reduction in IκB-β may contribute to persistent NF-κB activation in human endothelial cells. J. Biol. Chem. 271 (1996) 16317-16322
55. Brown M., McGuinness M., Wright T., Ren X., Wang Y., Boivin G.P., Hahn H., Feldman A.M., and Jones W.K. Cardiac-specific blockade of NF-κB in cardiac pathophysiology: differences between acute and chronic stimuli in vivo. Am. J. Physiol. Heart Circ. Physiol. 289 (2005) H466-H476
56. Karin M., Yamamoto Y., and Wang Q.M. The IKK NF-κB system: a treasure trove for drug development. Nat. Rev. Drug Discov. 3 (2004) 17-26